Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Raymond James Downgrades QuidelOrtho to Outperform, Lowers Price Target to $76

Author: Benzinga Newsdesk | February 14, 2024 09:30am
Raymond James analyst Andrew Cooper downgrades QuidelOrtho (NASDAQ:QDEL) from Strong Buy to Outperform and lowers the price target from $100 to $76.

Posted In: QDEL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist